CTOs on the Move

The Carolinas Center for Medical Excellence (CCM

www.mrnc.org

 
The Carolinas Center for Medical Excellence (CCME) is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mrnc.org
  • 100 Regency Forest Dr Ste 200
    Cary, NC USA 27518
  • Phone: 919.380.9860

Executives

Name Title Contact Details

Similar Companies

Genesis Engineers

Genesis Engineers Inc. is a Plymouth Meeting, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medigraphics Corporation

Medigraphics Corporation is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Centinel Spine

Centinel Spine is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stanford Medicine Children`s Health

Stanford Medicine Children`s Health, with Lucile Packard Children`s Hospital Stanford at its center, is the Bay Area`s largest health care system exclusively dedicated to children and expectant mothers. Our network of care includes more than 65 locations across Northern California and more than 85 locations in the U.S. Western region. Along with Stanford Health Care and the Stanford School of Medicine, we are part of Stanford Medicine, an ecosystem harnessing the potential of biomedicine through collaborative research, education, and clinical care to improve health outcomes around the world. We are a nonprofit organization committed to supporting the community through meaningful outreach programs and services and providing necessary medical care to families, regardless of their ability to pay.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.